Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Merck & Company Inc

MRK
Current price
125.37 USD -0.3 USD (-0.24%)
Last closed 125.06 USD
Sector Healthcare
Industry Drug Manufacturers - General
Exchange NYSE
Capitalization 316 780 707 840 USD
Yield for 12 month +9.18 %
1Y
3Y
5Y
10Y
15Y
MRK
21.11.2021 - 28.11.2021

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes under the Keytruda, Bridion, Adempas, Lagevrio, Belsomra, Simponi, and Januvia brands, as well as vaccine products consisting of preventive pediatric, adolescent, and adult vaccines under the Gardasil/Gardasil 9, ProQuad, M-M-R II, Varivax, RotaTeq, Live Oral, Vaxneuvance, Pneumovax 23, and Vaqta names. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. The company serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians, wholesalers, government entities, veterinarians, distributors, animal producers, farmers, and pet owners. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates, which include patritumab deruxtecan, ifinatamab deruxtecan, and raludotatug deruxtecan for the treatment of multiple solid tumors both as monotherapy and/or in combination with other treatments; and AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types, and Koselugo for multiple indications. The company also has a collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. was founded in 1891 and is headquartered in Rahway, New Jersey. Address: 126 East Lincoln Avenue, Rahway, NJ, United States, 07065

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

137.02 USD

P/E ratio

893.2857

Dividend Yield

2.46 %

Current Year

+59 871 000 000 USD

Last Year

+59 283 000 000 USD

Current Quarter

+14 630 000 000 USD

Last Quarter

+14 630 000 000 USD

Current Year

+43 894 000 000 USD

Last Year

+41 872 000 000 USD

Current Quarter

+11 290 000 000 USD

Last Quarter

+11 290 000 000 USD

Key Figures MRK

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA 8 296 999 936 USD
Operating Margin TTM 0.08 %
PE Ratio 893.2857
Return On Assets TTM 2.64 %
PEG Ratio 0.1008
Return On Equity TTM 0.9 %
Wall Street Target Price 137.02 USD
Revenue TTM 60 115 001 344 USD
Book Value 14.85 USD
Revenue Per Share TTM 23.7 USD
Dividend Share 2.92 USD
Quarterly Revenue Growth YOY 5.8 %
Dividend Yield 2.46 %
Gross Profit TTM 42 077 000 000 USD
Earnings Share 0.14 USD
Diluted Eps TTM 0.14 USD
Most Recent Quarter I 2024
Quarterly Earnings Growth YOY 45.3 %
Profit Margin 0.61 %

Dividend Analytics MRK

Dividend growth over 5 years

56 %

Continuous growth

Payout Ratio 5 years average

81 %

Dividend History MRK

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate 3.08
Ex Dividend Date 14.03.2024
Forward Annual Dividend Yield 2.46 %
Last Split Factor 1048:1000
Payout Ratio 2 %
Last Split Date 03.06.2021
Dividend Date 05.04.2024

Stock Valuation MRK

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE 893.2857
Forward PE 14.6843
Enterprise Value Revenue 5.7634
Price Sales TTM 5.2982
Enterprise Value EBITDA 50.1614
Price Book MRQ 8.4751

Financials MRK

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators MRK

For 52 weeks

97.81 USD 133.1 USD
50 Day MA 126.1 USD
Shares Short Prior Month 16 604 734
200 Day MA 112.47 USD
Short Ratio 1.77
Shares Short 19 592 222
Short Percent 0.77 %

Dynamics of changes in the value of assets

Stocks


MSFT

MSFT

411.84 USD Microsoft Corporation -5.76 (-1.38%)
Detailed analytics

ETF funds


M

MDAXEX

208.40 CHF iShares MDAX UCITS ETF (DE) -12.16 (-5.06%)
Detailed analytics

Metals


Gold

2205.6 USD Gold +35.66 (+1.64%)
Detailed analytics